Recent News About Hesperos and Human-on-a-Chip Technology

Hesperos Presentation at NIH Rare Disease Day: 2/29/2024

By Hesperos | March 4, 2024 | 0 Comments

Hesperos Chief Scientist Dr. J Hickman was a featured speaker at Rare Disease Day at NIH discussing how Human-on-a-Chip systems are actively supporting therapeutic development for Rare Diseases. Watch his presentation here.

Functional Overdose Model – New Study Published in Advanced Biology

By Hesperos | September 7, 2023 | 0 Comments

Development of an Overdose Model Press Release Link to Publication This research provides an accurate way to model overdose in the lab, using human brain cells programmed to respond to many different opioids. Amid an … Read More

New Publication in Nature Scientific Reports: Malaria-on-a-Chip

By Hesperos | July 5, 2023 | 0 Comments

Development of a Malaria-on-a-Chip Model Model developed to study Malaria and potential therapeutics Press Release Link to Publication Hesperos scientists have published a groundbreaking study in Scientific Reports, a Nature journal. The publication, titled “Development … Read More

Hesperos Chief Scientist quoted in Nature Medicine Feature on State of the Field

By Hesperos | June 14, 2023 | 0 Comments

Hesperos Chief Scientist quoted in the Nature Medicine article discussing the state of the field, including rapid advancement with the adoption of the FDA Modernization Act 2.0.

FDA Modernization Act 2.0 – Animal testing mandate eliminated

By Hesperos | January 17, 2023 | 0 Comments

The FDA Modernization Act 2.0 was signed into law eliminating the animal testing mandate in drug discovery.

Chief Scientist named Researcher of the Year by Bioflorida

By Hesperos | November 8, 2022 | 0 Comments

Hesperos Chief Scientist, Dr. James Hickman, awarded Researcher of the Year at the 2022 BioFlorida conference in Miami

Unique human neuromuscular junction assay establishes skeletal muscle as a key player in ALS

By Hesperos | October 18, 2022 | 0 Comments

In a recent study published in Biomaterials, a team of researchers led by Hesperos Chief Scientist Dr. J. Hickman established a significant finding to better understand ALS etiology and potential new treatment targets.